Development Pipeline
PF-655
QPI-1002
QPI-1007
siRNA Drug Candidate Pipeline
Disease Indications
Letter from the CEO
Company Profile
Management
Board of Directors
Mission, Vision and Values
Licensing Partners
News
Careers
Overview
News
Overview
Current Collaborations
ClinicalStudies
SiRNA
Intellectual Property
About Us
Product Candidates
Research & Development
Investor Relations
Contact
Development Pipeline
PF-655
QPI-1002
QPI-1007
siRNA Drug Candidate Pipeline
Disease Indications
Letter from the CEO
Company Profile
Management
Board of Directors
Mission, Vision and Values
Licensing Partners
News
Careers
Overview
News
Overview
Current Collaborations
ClinicalStudies
SiRNA
Intellectual Property
About Us
Product Candidates
Research & Development
Investor Relations
Contact
9/26/2006
Pfizer and Quark
Pfizer expands research commitment to ophthalmology through licensing agreement with quark biotech...
Read More>
2010
2009
2008
2007
2006
2005
Home
Products
Contact
©2007 Quark Pharmaceuticals, Inc.